Menu

Primary Care
Internal Medicine
Our MissionOur Team
AutoimmuneCardiovascularDermatologicEndocrineENTGastrointestinalGenito-UrinaryHematologyAllergy & ImmunologyKidneyMusculoskeletalNeurologicOphthalmologyPeptide TherapyPsychiatricPulmonarySleepWeight Loss (GLP-1)
All Health ConditionsCardiovascularDermatologicEndocrineENTGastrointestinalGenito-UrinaryHematologyImmunologyMusculoskeletalNeurologicOphthalmologyPsychiatricPulmonary
Medication GuidePatient FormsYour First VisitPatient ResourcesLab WorkSupplementsPatient PortalHIPAA PrivacyLocal VitalsFAQ
Outbreaks
Contact Us

Peptide Therapy in St. Petersburg

Physician guidance on peptides, from FDA-approved medicines like semaglutide and teriparatide to the compounded and "research" peptides sold online. Our internists help you sort out what is proven, what is allowed, and what is safe for you.

Call (727) 820-7800

What Peptides Are, and Why the Label Matters

Peptides are short chains of amino acids, the same building blocks that make up proteins. Your body uses them as chemical signals: insulin, glucagon, oxytocin and the gut hormone GLP-1 are all peptides. Because they act on specific receptors, peptides can make precise and powerful medicines.

“Peptide therapy” now describes two very different things. One is a growing list of FDA-approved prescription drugs, tested in large clinical trials and made under FDA oversight. The other is a market of compounded and “research use only” peptides, such as BPC-157, TB-500 and CJC-1295, that have not been approved for any use in people. Knowing which group a peptide belongs to is the first step in judging whether it is worth the risk.

Our internists prescribe FDA-approved peptide medicines when they fit your health goals, and we are glad to review any peptide you are taking or considering.

FDA-Approved Peptide Medicines

GLP-1 medications for diabetes and weight, bone-building peptides for osteoporosis, and peptide treatments for constipation, IBS and other conditions.

An Honest Look at Compounded Peptides

What the research actually shows, where each peptide stands with the FDA, and what is known about quality and safety.

Labs and Monitoring

Baseline and follow-up blood work, such as blood sugar, kidney function and IGF-1, so treatment is checked rather than guessed at.

FDA-Approved Peptide Medicines

These peptides have passed FDA review for safety and effectiveness in specific conditions. Each is a prescription medicine, and whether one fits you depends on your diagnosis and health history.

  • Semaglutide

    Ozempic, Rybelsus, Wegovy (injection and pill)

    Type 2 diabetes; chronic weight management; lowering the risk of heart attack and stroke in adults with heart disease and obesity or overweight (Wegovy).

  • Tirzepatide

    Mounjaro, Zepbound

    Type 2 diabetes (Mounjaro); chronic weight management and moderate to severe obstructive sleep apnea in adults with obesity (Zepbound).

  • Liraglutide

    Victoza, Saxenda

    Type 2 diabetes (Victoza); chronic weight management (Saxenda).

  • Insulin

    Many brands

    Type 1 and type 2 diabetes. Insulin is a 51-amino-acid peptide hormone and one of the oldest peptide medicines.

  • Teriparatide and abaloparatide

    Forteo, Tymlos

    Osteoporosis in people at high risk of fracture. These build new bone rather than only slowing bone loss.

  • Calcitonin salmon

    Miacalcin

    Paget disease of bone, high blood calcium, and postmenopausal osteoporosis in selected patients.

  • Linaclotide and plecanatide

    Linzess, Trulance

    Chronic idiopathic constipation and irritable bowel syndrome with constipation (IBS-C).

  • Tesamorelin

    Egrifta

    Reducing excess belly fat in adults with HIV-associated lipodystrophy. It is a growth hormone-releasing hormone analog, the same class as sermorelin and CJC-1295.

  • Bremelanotide (PT-141)

    Vyleesi

    Acquired, generalized hypoactive sexual desire disorder (low sexual desire) in premenopausal women.

  • Octreotide

    Sandostatin and others

    Acromegaly and the symptoms of certain hormone-secreting tumors.

  • Desmopressin

    DDAVP and others

    Central diabetes insipidus and certain types of bedwetting and nighttime urination.

  • Leuprolide

    Lupron Depot and others

    Advanced prostate cancer, endometriosis, certain uterine fibroids, and early puberty in children.

Compounded and “Research” Peptides: Where They Stand

Regulatory status as of October 27, 2026. This area is changing quickly, and we update this page as FDA acts.

Most peptides marketed for healing, anti-aging, muscle gain or fat loss are not FDA-approved drugs. Clinics get them from compounding pharmacies, and many people buy vials online labeled “research use only.” Federal law limits which ingredients a pharmacy may use in a compounded drug, and FDA keeps public lists of the substances it has reviewed.

  1. 2023

    FDA placed BPC-157, TB-500, CJC-1295, ipamorelin, AOD-9604, thymosin alpha-1 and many other peptides in “Category 2,” its list of bulk substances that may raise significant safety risks in compounded drugs. FDA cited the risk of immune reactions, problems with peptide impurities, and little or no safety information for the ways these peptides are used.

  2. 2024 to April 2026

    After the groups that nominated them withdrew their nominations, FDA moved 16 peptides off Category 2, including BPC-157, TB-500, CJC-1295, AOD-9604, thymosin alpha-1, Selank, Semax, Epitalon, injectable GHK-Cu, LL-37 and melanotan II. FDA stated that removal does not make a peptide eligible for compounding.

  3. July 2026

    FDA's Pharmacy Compounding Advisory Committee voted to recommend adding six peptides (BPC-157, TB-500, KPV, MOTS-c, Epitalon and Semax) to the list of ingredients pharmacies may compound from, and voted against emideltide (DSIP). FDA's own reviewers had recommended against most of them. The votes are advice only, and FDA has not acted on them.

  4. October 2026

    HHS and FDA sent an “interim access policy” for compounding certain peptides to the White House Office of Management and Budget for review. Its contents have not been published.

Still on FDA's Category 2 list: ibutamoren (MK-677), kisspeptin-10, GHRP-2, GHRP-6, and ipamorelin for outsourcing facilities.

What this means for you

As of today, none of these peptides is FDA-approved for any use, and none has been added to the list of ingredients pharmacies may compound from. Products sold online as “research chemicals” are not made or tested for use in people, and FDA has sent warning letters to online sellers of them.

Peptides Patients Ask Us About

What each one is, what the evidence shows, and where it stands.

  • BPC-157

    Not FDA-approved

    A lab-made peptide based on a fragment of a protein found in stomach juice, promoted for tendon, joint and gut healing. Nearly all of the research is in animals and cell cultures; the human data come from a handful of very small studies without comparison groups. Long-term safety is unknown, and it is prohibited in sport.

  • TB-500

    Not FDA-approved

    A synthetic fragment of thymosin beta-4, a natural repair protein. It is sold for muscle and tendon recovery on the strength of animal studies; there are no published clinical trials showing that it heals injuries in people. It is also prohibited in sport.

  • CJC-1295, ipamorelin and sermorelin

    Not FDA-approved

    These signal the pituitary gland to release more growth hormone and are sold for muscle, fat loss and “anti-aging.” Raising growth hormone in adults without a true deficiency has not been shown to make people healthier or live longer, and growth hormone itself can cause fluid retention, joint pain and higher blood sugar. Sermorelin was once approved as Geref, but that brand was discontinued in 2008. The FDA-approved drug in this class is tesamorelin, for one narrow use.

  • Ibutamoren (MK-677)

    On FDA safety-risk list

    Often sold alongside peptides, but it is a pill, not a peptide. It remains on FDA's list of substances that may pose significant safety risks in compounding. In a clinical trial in older adults it raised fasting blood sugar and lowered insulin sensitivity.

  • GHK-Cu (copper peptide)

    Cosmetic use only

    Common in skin-care creams and serums, where it is sold as a cosmetic ingredient. Injectable GHK-Cu is not FDA-approved and is expected to go before FDA's compounding advisory committee by early 2027.

  • PT-141 and melanotan II

    One approved, one not

    PT-141 is bremelanotide, FDA-approved as Vyleesi for low sexual desire in premenopausal women. Melanotan II, a related tanning peptide sold online, is not approved. It darkens skin and moles, and doctors have reported new and changing moles, including melanomas, in people who use it.

  • Compounded semaglutide and tirzepatide

    Shortages over

    Pharmacies were allowed to make copies of these drugs during FDA-declared shortages, which ended for tirzepatide in late 2024 and for semaglutide in February 2025. FDA has received reports of dosing errors and side effects with compounded versions. Read more in our guide to compounded semaglutide safety warnings.

  • Collagen peptides

    Dietary supplement

    A food supplement, not a drug: collagen broken into small pieces so it can be absorbed. Small randomized trials suggest modest benefits for skin hydration and elasticity, and evidence for joint pain is mixed. See our collagen supplement.

Conditions Treated With FDA-Approved Peptides

ObesityDiabetesOsteoporosisObstructive Sleep ApneaIrritable Bowel SyndromeChronic Constipation

How We Help With Peptide Questions

  1. Start with your goal

    Weight, blood sugar, bone strength, recovery from an injury, energy, or sexual health. Often there is an FDA-approved treatment, or a diagnosis such as an underactive thyroid, sleep apnea or low testosterone, that explains the problem better than a peptide would.

  2. Review what you are taking

    Bring the vial, the label, or the website you ordered from. We look at the ingredient, where it was made, and how it could interact with your other medications and conditions.

  3. Check the right labs

    Depending on the peptide, that may include A1c and blood sugar, kidney and liver function, cholesterol, and IGF-1 for growth hormone-releasing peptides. See our in-office lab work.

  4. Treat and follow up

    FDA-approved peptide medicines such as GLP-1 medications are started at a low dose and adjusted at follow-up visits, with attention to side effects and to how you are progressing toward your goal.

When to get help after a peptide injection

Call 911 for hives with swelling of the lips or tongue, trouble breathing, or fainting. Call us the same day for redness or swelling that spreads from the injection site, fever, a painful lump under the skin, or severe belly pain or vomiting while taking a GLP-1 medication.

Peptide Therapy Questions

Do you offer peptide therapy in St. Petersburg?

We prescribe FDA-approved peptide medicines when they fit your diagnosis and goals, including GLP-1 medications such as semaglutide and tirzepatide, bone-building peptides for osteoporosis, and peptide treatments for constipation and IBS. If you are using or considering another peptide, we will review it with you, check the evidence and your labs, and help you weigh the risks.

Is BPC-157 FDA-approved or legal to compound?

No. BPC-157 is not approved by FDA for any use. FDA removed it from its significant-safety-risk compounding list in April 2026, but said that did not make it eligible for compounding. An FDA advisory committee voted in July 2026 to recommend allowing it, and FDA has not yet acted on that vote. It is also prohibited in sport by the World Anti-Doping Agency.

Are GLP-1 medications peptides?

Yes. Semaglutide, tirzepatide and liraglutide are lab-made peptides modeled on gut hormones, and they are the most widely used peptide medicines today. They are FDA-approved for type 2 diabetes and chronic weight management and, depending on the drug, for lowering heart attack and stroke risk or treating obstructive sleep apnea.

Can peptides slow aging?

There is no good evidence that any peptide slows aging in people. Growth hormone-releasing peptides raise growth hormone and IGF-1, but higher levels in adults without a true deficiency have not been shown to extend life, and they can raise blood sugar. Exercise, sleep, blood pressure control and recommended cancer screening remain the best-supported ways to stay healthy longer.

Are peptides bought online safe to inject?

There is no assurance that a vial sold as a research chemical or "not for human use" contains what the label says, in the stated amount, or that it is sterile. These products are not made to the standards required for injectable medicines, and injecting a contaminated product can cause a serious infection. FDA has sent warning letters to online sellers of these peptides.

What is the difference between sermorelin and tesamorelin?

Both are lab-made versions of growth hormone-releasing hormone. Tesamorelin (Egrifta) is FDA-approved for one use: reducing excess belly fat in adults with HIV-associated lipodystrophy. Sermorelin was once approved, as Geref, for children with growth hormone deficiency, but that brand was discontinued in 2008, so sermorelin sold today comes from compounding pharmacies.

Are peptides the same as steroids?

No. Anabolic steroids are hormones built from cholesterol, while peptides are short chains of amino acids. Even so, many peptides, including BPC-157, TB-500 and the growth hormone-releasing peptides, are on the World Anti-Doping Agency prohibited list, so athletes who are drug tested should assume they are banned.

Does insurance cover peptide therapy?

Coverage for FDA-approved peptide medicines depends on your plan and the condition being treated. Many plans cover GLP-1 medicines for type 2 diabetes but have separate rules for weight loss. Compounded peptides are generally not covered by insurance and are paid out of pocket.

Talk With a Physician About Peptides

Whether you are curious about a GLP-1 medication or already using a peptide from another clinic, call to schedule a visit with our internal medicine team in St. Petersburg.

Call (727) 820-7800

References

Trusted Resources for Peptide Medicines

For further reading, our team recommends the following authoritative sources. These external links open in a new tab.